Organization
Centre Hospitalier de l'Université de Montréal (CHUM)-Notre Dame
5 abstracts
Abstract
Phase II randomized multi-centre study of neoadjuvant olaparib in patients with platinum sensitive relapsed high grade serous ovarian cancer: The NEO trial.Org: Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada, Auckland City Hospital and University of Auckland, Auckland, New Zealand,
Abstract
A 16 year-retrospective study of refractory meningiomas: Prognostic factors and systemic treatments.Org: Centre Hospitalier de l'Université de Montréal (CHUM)-Notre Dame, Montréal, QC, Canada,
Abstract
Real-world treatment practices in patients with muscle invasive bladder cancer (MIBC) treated in Alberta, Canada.Org: University of Calgary, Department of Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan, Princess Margaret Cancer Center, University Health Network, University of British Columbia,
Abstract
Artemin and immune checkpoint inhibitor (ICI) efficacy in metastatic colorectal cancer (mCRC): A correlative analysis of the Canadian Cancer Trials Group (CCTG) CO.26 trial.Org: Princess Margaret Cancer Centre, University Health Network, Genome Sciences Centre, BCCA, The Ottawa Hospital Cancer Centre, Oregon Health & Science University,
Abstract
Use of positron emission tomography-computed tomography (PET-CT) scan in cancer patients: A single Canadian academic oncology center experience.Org: Centre Hospitalier Régional de Lanaudière, Université de Montreal, Centre hospitalier de l'Université de Montréal, Centre Hospitalier de l'Université de Montréal (CHUM)-Notre Dame,